RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases

Схожие документы

• Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases
  по: Andreou, Andreas, et al.
  Опубликовано: (2012)
• RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy prior to resection of colorectal liver metastases
  по: Zimmitti, Giuseppe, et al.
  Опубликовано: (2014)
• Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate
  по: Andreou, Andreas, et al.
  Опубликовано: (2011)
• Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point Before Resection of Hepatic Colorectal Metastases
  по: Shindoh, Junichi, et al.
  Опубликовано: (2012)
• Margin Status Remains an Important Determinant of Survival after Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
  по: Andreou, Andreas, et al.
  Опубликовано: (2013)